Third-Party Social Media: Firms Should Not Be Selective In Corrections

Companies that want to correct misinformation about their devices posted on third-party social media sites should correct all of the information within a defined area of the forum, including exaggerated efficacy claims, FDA urges in a draft guidance.

“For example, if a firm chooses to correct only misinformation that portrays its product in a negative light in a third-party communication but does not address information that overstates the benefits of its product in that same clearly defined portion of the communication,